Development of Laboratory Medicine in Europe
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Development of Laboratory Medicine in Europe

on

  • 1,025 views

 

Statistics

Views

Total Views
1,025
Views on SlideShare
1,025
Embed Views
0

Actions

Likes
0
Downloads
15
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Development of Laboratory Medicine in Europe Presentation Transcript

  • 1. Laboratory medicine Multidisciplinary branch of medicine providing the health care system with laboratory results.... (R.Dybkaer) Medical laboratory ISO 15189, 3.8: laboratory for the biological, microbiological, immunological, chemical, immunohaematological, biophysical, cytological, pathological, or other examination of materials derived from the human body....
  • 2. Future trends and challenges
    • Financial limitations forces concentration of resources
    • Overlapping techniques also require laboratories
    • "without walls"
    • 3. Genomics, transcriptomics, proteonomics, metabolomics
    • 4. Professional expertise
    • Improvement of quality of service and of consultation
    • in the sense of TDM
    • POCT engagement of central laboratories
    • Justification of laboratory medicine as a discipline
  • 3. Competence centre for LM 1.Step: integration of clinical microbiology in the central laboratory = Institute for Laboratory Medicine 2.Step: Private limited liability company (community 49 %, private group 51 %) 3.Step: Concentration of several disciplines in one building (laboratory medicine, blood bank, hygiene, human genetics, etc.) 4.Step: Further consolidation towards one organisational unit (?)
  • 4. Benefits of concentration
    • broaden financial resources
    • eliminate dual financial system
    • focussing competence (more specialists)
    • providing more efficient regional patient care
  • 5. Future trends and challenges
    • Financial limitations forces concentration of resources
    • Overlapping techniques also require
    • laboratories "without walls"
    • 3. Genomics, transcriptomics, proteonomics, metabolomics
    • 4. Professional expertise
    • Improvement of quality of service and of consultation
    • in the sense of TDM
    • POCT engagement of central laboratories
    • Justification of laboratory medicine as a discipline
  • 6. Future trends and challenges
    • Financial limitations forces concentration of resources
    • Overlapping techniques also require laboratories
    • " without walls"
    • Genomics, transcriptomics, proteonomics,
    • metabolomics
    • 4. Professional expertise
    • Improvement of quality of service and of consultation
    • in the sense of TDM
    • POCT engagement of central laboratories
    • Justification of laboratory medicine as a discipline
  • 7. Future trends and challenges
      • Genomics, transcriptomics, proteonomics,
      • metabolomics
    • - traditional genetic diseases (CAH)
    • - gene expression in oncology (cancer diagnosis)
    • - tailored pharmacotherapy (TDM)
    • - infectious diseases
  • 8. breast cancer 7 – 10 % herediterally determined 80 % due to BRCA 1 and 2 80 % of BRCA 1 carriers develop breast cancer Up to the age of 70
  • 9. Future trends and challenges
      • Genomics, transcriptomics, proteonomics,
      • Metabolomics
    • - traditional genetic diseases (CAH)
    • - gene expression in oncology (cancer diagnosis)
    • - tailored pharmacotherapy (TDM)
    • - infectious diseases
  • 10. Future trends and challenges
      • Genomics, transcriptomics, proteonomics,
      • Metabolomics
    • - traditional genetic diseases (CAH)
    • - gene expression in oncology (cancer diagnosis)
    • - tailored pharmacotherapy (TDM)
    • - infectious diseases
  • 11. Trend to miniaturization in laboratory medicine Floor standing bench top portable handhold microchip nanochip
  • 12. Future trends and challenges
    • Financial limitations forces concentration of resources
    • Overlapping techniques also require laboratories
    • "without walls"
    • 3. Genomics, transcriptomics, proteonomics, metabolomics
    • 4. Professional expertise
    • Improvement of quality of service and of consultation
    • in the sense of TDM
    • POCT engagement of central laboratories
    • Justification of laboratory medicine as a discipline
  • 13.  
  • 14. Future trends and challenges
    • Financial limitations forces concentration of resources
    • Overlapping techniques also require laboratories
    • "without walls"
    • 3. Genomics, transcriptomics, proteonomics, metabolomics
    • 4. Professional expertise
    • Improvement of quality of service and
    • of consultation in the sense of TDM
    • POCT engagement of central laboratories
    • Justification of laboratory medicine as a discipline
  • 15.  
  • 16. blood glucose (mg / dl) reference intervals (textbooks) decision limits (WHO) type 2 DM IGT VP 0 70 – 115 126 110 VP 2h 200 140 VB 0 60 – 100 110 100 VB a,0 135 118 VB 2h 180 120 VB a,2h 194 150 CP 0 126 110 CP 2h 220 140 CB 0 70 – 100 110 100 CB 2h 200 140 CB a,0 135 118 CB a,2h 237 150
  • 17. Future trends and challenges
    • Financial limitations forces concentration of resources
    • Overlapping techniques also require laboratories
    • "without walls"
    • 3. Genomics, transcriptomics, proteonomics, metabolomics
    • 4. Professional expertise
    • Improvement of quality of service and of consultation
    • in the sense of TDM
    • POCT engagement of central laboratories
    • Justification of laboratory medicine as a discipline
  • 18. Strategies of central laboratories for engagement in POCT
    • The top management should decide on the responsibilities
    • Installation of a POCT commission chaired by the
    • laboratory director(selection and justification of POCT
    • instruments, quality assurance program,
    • comparability of results with laboratory results)
    • Nomination of a POCT coordinator
    • 4. On-line network between laboratory and POCT stations
  • 19. Indications for POCT glucose
    • at least 5 tests per week
    • insulin therapy
    • suspicion for hypoglycemia
    • training of patients
    • not for diagnosing type 2 DM or glucose intolerance
  • 20. Future trends and challenges
    • Financial limitations forces concentration of resources
    • Overlapping techniques also require laboratories
    • "without walls"
    • 3. Genomics, transcriptomics, proteonomics, metabolomics
    • 4. Professional expertise
    • Improvement of quality of service and of consultation
    • in the sense of TDM
    • POCT engagement of central laboratories
    • Justification of laboratory medicine as
    • a discipline
  • 21. Evaluation of method comparisons
    • 1.Step
    • definition of the analytical comparability
    • (conventual concept)
    • 2.Step
    • determination of the diagnostic relevance
    • (future concept)
  • 22. Summary
    • Vision: same quality and comparable results in Europe by
    • means of harmonisation of methods, of reference intervals,
    • development of decision limits and the same
    • accreditation system. ELM tries to support these goals.
    • all disciplines must come under one roof or on one platform
    • in so-called competence centres which should be organized
    • on a regional basis servicing a population of 0.5 to 1.0
    • million people. If the region is spread, especially in
    • rural areas, satellite laboratories may be required.
    • Several competence centres can co-operate for
    • special expertise.